Recurrent ruptured abdominal aneurysms in polyarteritis nodosa successfully treated with infliximab

Código QR

Recurrent ruptured abdominal aneurysms in polyarteritis nodosa successfully treated with infliximab

Butsabong Lerkvaleekul,1 Suporn Treepongkaruna,2 Nichanan Ruangwattanapaisarn,3 Tharintorn Treesit,3 Soamarat Vilaiyuk11Division of Rheumatology, Department of Paediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 2Division of Gastroenterology, Department of P...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lerkvaleekul B, Treepongkaruna S, Ruangwattanapaisarn N, Treesit T, Vilaiyuk S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Vasculitis Gastrointestinal bleeding Tumor necrosis factor Infliximab Biologic therapy Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/db952d31e76f414a939f6076427d4299
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Evaluación del tratamiento con infliximab en enfermos con artritis inflamatoria refractaria a drogas habituales
por: Labarca S,Cristián, et al.
Publicado: (2003)

Infliximab en el tratamiento de la enfermedad de Crohn: Estudio preliminar
por: Gellona V,José, et al.
Publicado: (2006)

Endovascular Biopsy of Vertebrobasilar Aneurysm in Patient With Polyarteritis Nodosa
por: Kazim H. Narsinh, et al.
Publicado: (2021)

Eficacia del infliximab en pacientes con síndrome de Behçet portadores de úveo-retinitis grave
por: Merino,Guillermo, et al.
Publicado: (2006)

Rol de infliximab en enfermedad inflamatoria intestinal: Experiencia local
por: Simian,Daniela, et al.
Publicado: (2013)

Eficacia y seguimiento en el largo plazo de pacientes con psoriasis vulgar moderada a severa en tratamiento con infliximab (Remicade®)
por: Valdés A,María del Pilar, et al.
Publicado: (2006)

Terapia de inducción acelerada con infliximab en paciente con colitis ulcerosa grave refractaria a corticoides. Caso clínico
por: Fluxá,Daniela, et al.
Publicado: (2017)

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
por: Fitzgerald T, et al.
Publicado: (2021)

Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
por: Salehzadeh F, et al.
Publicado: (2019)

A young girl with severe polyarteritis nodosa successfully treated with tocilizumab: a case report
por: Margaux Boistault, et al.
Publicado: (2021)

Acute pancreatitis as a presenting feature in a child with systemic polyarteritis nodosa
por: Sunil V Kapur, et al.
Publicado: (2021)

Pathogenetic role of tumor necrosis factor (TNF-α) for the development of peritoneal tuberculosis in an experiment
por: D. V. Plotkin, et al.
Publicado: (2021)

Utilidad de la monitorización terapéutica de infliximab en el manejo de la enfermedad inflamatoria intestinal
por: Quera,Rodrigo, et al.
Publicado: (2018)

Systematic review of immunomodulatory therapies for hidradenitis suppurativa
por: Lim SYD, et al.
Publicado: (2019)

Severe gastrointestinal bleeding in patients with atrial fibrillation receiving oral anticoagulants (based on REGistry of long-term AnTithrombotic TherApy – REGATTA)
por: Ekaterina S. Kropacheva, et al.
Publicado: (2021)

Tumor inflamatorio miofibroblástico peritoneal. Respuesta favorable asociada a infliximab: Caso clínico
por: Grünholz,Daniela, et al.
Publicado: (2015)

Clinical presentations and long term prognosis of childhood onset polyarteritis nodosa in single centre of Korea
por: Jeong-Seon Lee, et al.
Publicado: (2021)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto S, et al.
Publicado: (2018)

Transcatheter Arterial Embolization in Acute Non-Variceal Gastrointestinal Bleedings: A Ten-Year Single-Center Experience in 91 Patients and Review of the Literature
por: Federico Fontana, et al.
Publicado: (2021)

Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease
por: Katsuyama A, et al.
Publicado: (2019)

Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study
por: Mohammad Shehab, et al.
Publicado: (2021)

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
por: Viscido A, et al.
Publicado: (2019)

Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction
por: Youlian Zhou, et al.
Publicado: (2018)

Infliximab in Combination with Low-Dose Acitretin in Generalized Pustular Psoriasis: A Report of Two Cases and Review of the Literature
por: Kołt-Kamińska M, et al.
Publicado: (2021)

Chronic gastrointestinal bleeding caused by a Dieulafoy’s lesion in the small intestine: a case report
por: Javad Salimi, et al.
Publicado: (2021)

Long-term safety and efficacy of biosimilar infliximab among patients with inflammatory arthritis switched from reference product
por: Abdalla A, et al.
Publicado: (2017)

ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
por: E. V. Voronina, et al.
Publicado: (2018)

DYNAMICS OF CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS AS INFLUENCED BY INFLIXIMAB (REMIKEID) ADMINISTRATION
por: E. S. Zhugrova, et al.
Publicado: (2014)

Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results
por: Nozaki Y, et al.
Publicado: (2018)

Mesenteric Variceal Haemorrhage and Ectopic Cushing’s Syndrome as Presenting Features of a Pancreatic Neuroendocrine Tumour Recurrence
por: Scott Weerasuriya, et al.
Publicado: (2021)

Remicade® (infliximab): 20 years of contributions to science and medicine
por: Melsheimer R, et al.
Publicado: (2019)

Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment—A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model
por: David Ternant, et al.
Publicado: (2021)

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
por: Alvisi P, et al.
Publicado: (2019)

SX-ELLA Danis-Stent for Refractory Acute Esophageal Variceal Bleeding
por: Pedro Currais, et al.
Publicado: (2021)

Pseudotumor cerebri como una manifestación excepcional de la enfermedad de Behçet: Caso clínico
por: DURÁN,JOSEFINA, et al.
Publicado: (2010)

Validation and modification of existing mortality prediction models for lower gastrointestinal bleeding: a retrospective study
por: Hyun Seok Lee, et al.
Publicado: (2021)

Does the Intraluminal Thrombus Provoke the Rupture of the Abdominal Aortic Aneurysm Wall?
por: Mohammed Almijalli
Publicado: (2021)

PIODERMA GANGRENOSO GIGANTE DE CURSO FULMINANTE ASOCIADO A ENFERMEDAD INFLAMATORIA INTESTINAL
por: Bannura C,Guillermo, et al.
Publicado: (2014)

Sinistral Portal Hypertension after Pancreaticoduodenectomy with Splenic Vein Resection: Pathogenesis and Its Prevention
por: Yoshihiro Ono, et al.
Publicado: (2021)

ENDOSCOPIC FINDING IN PATIENTS PRESENTING WITH LOWER GASTROINTESTINAL BLEED - A STUDY FROM A DEVELOPING COUNTRY
por: Nadeem Zia, et al.
Publicado: (2021)